MK

Mikhail Karbachinskiy

Active Director Director DIN 08248817
DIN 08248817 First appointment Oct 2018 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2018
Shareholding value •••• Premium profile

About Mikhail Karbachinskiy

Data last updated:

Mikhail Karbachinskiy is a Director at Kmk Pharma Consulting Private Limited (since 2018). The company operates in Information Technology. Kmk Pharma Consulting Private Limited reported revenue of ₹19.02 Cr (FY 2025).

DIN 08248817
Primary Designation Director
Industry Information Technology
First Appointment 04 Oct 2018
Oldest Company Age 8 yrs
Largest company Kmk Pharma Consulting Private Limited · ₹19.02 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Oct 20182018₹19.02 Cr (FY 2025)Active

Board colleagues of Mikhail Karbachinskiy

NameDINCompanyDesignation
Esha Panneshkumar Patel08248818Kmk Pharma Consulting Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kmk Pharma Consulting Private Limited
Premium access

Shareholding and investment profile for Mikhail Karbachinskiy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mikhail Karbachinskiy

Mikhail Karbachinskiy currently holds 1 directorship: Kmk Pharma Consulting Private Limited (Director, since 04 Oct 2018, revenue ₹19.02 Cr (FY 2025)).

Mikhail Karbachinskiy was first appointed on 04 Oct 2018 as Director at Kmk Pharma Consulting Private Limited.

The current boards of Mikhail Karbachinskiy's companies include Esha Panneshkumar Patel (Kmk Pharma Consulting Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available